These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 8194748)
1. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors. Broder CC; Kennedy PE; Michaels F; Berger EA Gene; 1994 May; 142(2):167-74. PubMed ID: 8194748 [TBL] [Abstract][Full Text] [Related]
2. Recombinant Vaccinia Viruses Coding Transgenes of Apoptosis-Inducing Proteins Enhance Apoptosis But Not Immunogenicity of Infected Tumor Cells. Koval O; Kochneva G; Tkachenko A; Troitskaya O; Sivolobova G; Grazhdantseva A; Nushtaeva A; Kuligina E; Richter V Biomed Res Int; 2017; 2017():3620510. PubMed ID: 28951871 [TBL] [Abstract][Full Text] [Related]
3. Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies. Azad T; Rezaei R; Singaravelu R; Pelin A; Boulton S; Petryk J; Onsu KA; Martin NT; Hoskin V; Ghahremani M; Marotel M; Marius R; He X; Crupi MJF; Hoang HD; Nik-Akhtar A; Ahmadi M; Zamani NK; Golshani A; Alain T; Greer P; Ardolino M; Dickinson BC; Tai LH; Ilkow CS; Bell JC Nat Commun; 2023 May; 14(1):3035. PubMed ID: 37236967 [TBL] [Abstract][Full Text] [Related]
4. Use of recombinant vaccinia virus vectors for cell biology. Weisz OA; Machamer CE Methods Cell Biol; 1994; 43 Pt A():137-59. PubMed ID: 7823860 [TBL] [Abstract][Full Text] [Related]
5. Type I interferon-dependent CCL4 is induced by a cGAS/STING pathway that bypasses viral inhibition and protects infected tissue, independent of viral burden. Parekh NJ; Krouse TE; Reider IE; Hobbs RP; Ward BM; Norbury CC PLoS Pathog; 2019 Oct; 15(10):e1007778. PubMed ID: 31603920 [TBL] [Abstract][Full Text] [Related]
6. Cytokine Effects on the Entry of Filovirus Envelope Pseudotyped Virus-Like Particles into Primary Human Macrophages. Stantchev TS; Zack-Taylor A; Mattson N; Strebel K; Broder CC; Clouse KA Viruses; 2019 Sep; 11(10):. PubMed ID: 31547585 [TBL] [Abstract][Full Text] [Related]
7. Primary Human B Cells at Different Differentiation and Maturation Stages Exhibit Distinct Susceptibilities to Vaccinia Virus Binding and Infection. Shepherd N; Lan J; Li W; Rane S; Yu Q J Virol; 2019 Oct; 93(19):. PubMed ID: 31292245 [TBL] [Abstract][Full Text] [Related]
8. Differential Innate Immune Signaling in Macrophages by Wild-Type Vaccinia Mature Virus and a Mutant Virus with a Deletion of the A26 Protein. Kasani SK; Cheng HY; Yeh KH; Chang SJ; Hsu PW; Tung SY; Liang CT; Chang W J Virol; 2017 Sep; 91(18):. PubMed ID: 28659486 [TBL] [Abstract][Full Text] [Related]
9. A systemic macrophage response is required to contain a peripheral poxvirus infection. Davies ML; Parekh NJ; Kaminsky LW; Soni C; Reider IE; Krouse TE; Fischer MA; van Rooijen N; Rahman ZSM; Norbury CC PLoS Pathog; 2017 Jun; 13(6):e1006435. PubMed ID: 28614386 [TBL] [Abstract][Full Text] [Related]
16. Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II. Rehm KE; Connor RF; Jones GJ; Yimbu K; Mannie MD; Roper RL Immunology; 2009 Nov; 128(3):381-92. PubMed ID: 20067538 [TBL] [Abstract][Full Text] [Related]